Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | TAR-binding protein | 0.0063 | 0.1807 | 0.239 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0067 | 0.1933 | 0.1933 |
Brugia malayi | hypothetical protein | 0.0036 | 0.086 | 0.1137 |
Giardia lamblia | NADH oxidase lateral transfer candidate | 0.0032 | 0.074 | 0.5 |
Echinococcus granulosus | tar DNA binding protein | 0.0063 | 0.1807 | 0.297 |
Mycobacterium tuberculosis | Probable reductase | 0.0213 | 0.7029 | 0.8837 |
Echinococcus multilocularis | thioredoxin glutathione reductase | 0.0094 | 0.2884 | 0.4739 |
Echinococcus multilocularis | dihydrolipoamide dehydrogenase | 0.0032 | 0.074 | 0.1217 |
Echinococcus granulosus | dihydrolipoamide dehydrogenase | 0.0032 | 0.074 | 0.1217 |
Entamoeba histolytica | hypothetical protein | 0.0036 | 0.086 | 0.5 |
Toxoplasma gondii | thioredoxin reductase | 0.0094 | 0.2865 | 1 |
Brugia malayi | dihydrolipoyl dehydrogenase, mitochondrial precursor, putative | 0.0032 | 0.074 | 0.0979 |
Echinococcus multilocularis | tar DNA binding protein | 0.0063 | 0.1807 | 0.297 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0067 | 0.1933 | 1 |
Mycobacterium leprae | DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE | 0.0237 | 0.7856 | 1 |
Mycobacterium tuberculosis | Probable nitrite reductase [NAD(P)H] large subunit [FAD flavoprotein] NirB | 0.0213 | 0.7029 | 0.8837 |
Plasmodium falciparum | glutathione reductase | 0.0094 | 0.2865 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0036 | 0.086 | 0.5 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0094 | 0.2865 | 1 |
Echinococcus multilocularis | histone lysine methyltransferase setb histone lysine methyltransferase eggless | 0.0033 | 0.0754 | 0.1239 |
Loa Loa (eye worm) | TAR-binding protein | 0.0063 | 0.1807 | 0.239 |
Brugia malayi | Thioredoxin reductase | 0.0094 | 0.2865 | 0.3788 |
Echinococcus granulosus | histone lysine methyltransferase setb | 0.0033 | 0.0754 | 0.1239 |
Schistosoma mansoni | histone-lysine n-methyltransferase suv9 | 0.0033 | 0.0754 | 0.0754 |
Plasmodium vivax | glutathione reductase, putative | 0.0094 | 0.2865 | 1 |
Leishmania major | aldehyde dehydrogenase, mitochondrial precursor | 0.0067 | 0.1933 | 0.5614 |
Onchocerca volvulus | 0.0033 | 0.0754 | 0.0871 | |
Echinococcus multilocularis | histone lysine N methyltransferase SETMAR | 0.0033 | 0.0754 | 0.1239 |
Loa Loa (eye worm) | pre-SET domain-containing protein family protein | 0.0229 | 0.7563 | 1 |
Mycobacterium tuberculosis | NAD(P)H quinone reductase LpdA | 0.0237 | 0.7856 | 1 |
Echinococcus multilocularis | geminin | 0.0186 | 0.6086 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0063 | 0.1807 | 0.1807 |
Toxoplasma gondii | histone lysine methyltransferase SET/SUV39 | 0.0033 | 0.0754 | 0.0064 |
Plasmodium vivax | SET domain protein, putative | 0.0033 | 0.0754 | 0.0064 |
Brugia malayi | Pre-SET motif family protein | 0.0033 | 0.0754 | 0.0997 |
Entamoeba histolytica | hypothetical protein | 0.0036 | 0.086 | 0.5 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0033 | 0.0754 | 0.0754 |
Schistosoma mansoni | hypothetical protein | 0.0186 | 0.6086 | 0.6086 |
Mycobacterium tuberculosis | Probable aldehyde dehydrogenase | 0.0067 | 0.1933 | 0.1676 |
Mycobacterium tuberculosis | Probable dehydrogenase | 0.0213 | 0.7029 | 0.8837 |
Brugia malayi | RNA binding protein | 0.0063 | 0.1807 | 0.239 |
Loa Loa (eye worm) | RNA binding protein | 0.0063 | 0.1807 | 0.239 |
Entamoeba histolytica | hypothetical protein | 0.0036 | 0.086 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0063 | 0.1807 | 0.1807 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0036 | 0.086 | 0.1413 |
Plasmodium falciparum | thioredoxin reductase | 0.0094 | 0.2865 | 1 |
Mycobacterium tuberculosis | Probable NADH dehydrogenase Ndh | 0.0213 | 0.7029 | 0.8837 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0033 | 0.0754 | 0.0754 |
Trypanosoma brucei | trypanothione reductase | 0.0094 | 0.2865 | 1 |
Echinococcus granulosus | geminin | 0.0186 | 0.6086 | 1 |
Brugia malayi | glutathione reductase | 0.0094 | 0.2865 | 0.3788 |
Echinococcus granulosus | thioredoxin glutathione reductase | 0.0094 | 0.2884 | 0.4739 |
Mycobacterium tuberculosis | NADPH-dependent mycothiol reductase Mtr | 0.0094 | 0.2865 | 0.2985 |
Mycobacterium tuberculosis | Probable membrane NADH dehydrogenase NdhA | 0.0213 | 0.7029 | 0.8837 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0067 | 0.1933 | 1 |
Chlamydia trachomatis | dihydrolipoyl dehydrogenase | 0.0032 | 0.074 | 0.5 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0033 | 0.0754 | 0.0754 |
Schistosoma mansoni | tar DNA-binding protein | 0.0063 | 0.1807 | 0.1807 |
Schistosoma mansoni | tar DNA-binding protein | 0.0063 | 0.1807 | 0.1807 |
Brugia malayi | MH2 domain containing protein | 0.0131 | 0.4174 | 0.5519 |
Schistosoma mansoni | hypothetical protein | 0.0036 | 0.086 | 0.086 |
Loa Loa (eye worm) | glutathione reductase | 0.0094 | 0.2865 | 0.3788 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0131 | 0.4174 | 0.5519 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0067 | 0.1933 | 1 |
Treponema pallidum | NADH oxidase | 0.0032 | 0.074 | 0.5 |
Brugia malayi | Pre-SET motif family protein | 0.0229 | 0.7563 | 1 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0063 | 0.1807 | 0.239 |
Plasmodium vivax | thioredoxin reductase, putative | 0.0094 | 0.2865 | 1 |
Echinococcus granulosus | 5'partial|histone lysine N methyltransferase SETDB2 | 0.0032 | 0.0712 | 0.117 |
Leishmania major | trypanothione reductase | 0.0094 | 0.2865 | 1 |
Brugia malayi | Pyridine nucleotide-disulphide oxidoreductase, dimerisation domain containing protein | 0.0024 | 0.0441 | 0.0584 |
Loa Loa (eye worm) | thioredoxin reductase | 0.0094 | 0.2865 | 0.3788 |
Loa Loa (eye worm) | hypothetical protein | 0.0033 | 0.0754 | 0.0997 |
Onchocerca volvulus | 0.026 | 0.8661 | 1 | |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0036 | 0.086 | 0.1413 |
Schistosoma mansoni | tar DNA-binding protein | 0.0063 | 0.1807 | 0.1807 |
Mycobacterium tuberculosis | Dihydrolipoamide dehydrogenase LpdC (lipoamide reductase (NADH)) (lipoyl dehydrogenase) (dihydrolipoyl dehydrogenase) (diaphoras | 0.0237 | 0.7856 | 1 |
Schistosoma mansoni | dihydrolipoamide dehydrogenase | 0.0032 | 0.074 | 0.074 |
Trichomonas vaginalis | set domain proteins, putative | 0.026 | 0.8661 | 1 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.0237 | 0.7856 | 1 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0131 | 0.4174 | 0.5519 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0063 | 0.1807 | 0.239 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0067 | 0.1933 | 0.1933 |
Echinococcus granulosus | aldehyde dehydrogenase mitochondrial | 0.0067 | 0.1933 | 0.3176 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.0032 | 0.074 | 0.5 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0036 | 0.086 | 0.086 |
Brugia malayi | alpha keto acid dehydrogenase complex, E3 component, lipoamide dehydrogenase | 0.0024 | 0.0441 | 0.0584 |
Schistosoma mansoni | hypothetical protein | 0.0186 | 0.6086 | 0.6086 |
Mycobacterium tuberculosis | Putative ferredoxin reductase | 0.0213 | 0.7029 | 0.8837 |
Echinococcus multilocularis | aldehyde dehydrogenase, mitochondrial | 0.0067 | 0.1933 | 0.3176 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.0032 | 0.074 | 0.5 |
Toxoplasma gondii | aldehyde dehydrogenase | 0.0067 | 0.1933 | 0.5614 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.